7 completed, 4 active not recruiting, 3 unknown, 2 terminated. 6 Phase 2, 5 Not applicable, 5 Phase 1, 4 Phase 3, 1 Phase 4.
Follow Rhabdomyosarcoma, Alveolar: new trials by email Literature Review of Rhabdomyosarcoma, Alveolar trials Research Report on Rhabdomyosarcoma, Alveolar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy, Left Arm treated with vehicle serum and Intense Pulsed Light Therapy - Photodamaged Skin | Phase 2 / Phase 3 | Not yet recruiting | Goldman, Butterwick, Fitzpatrick and Groff | 20 | 2026-07-10 | 2026-07-07 |
| Laser to Aid in Treatment of Keratosis Pilaris on Arms M22 IPL - Keratosis Pilaris | Not applicable | Unknown | Goldman, Butterwick, Fitzpatrick and Groff | 10 | 2023-03-20 | 2023-03-20 |
| Sculptra to Aid in Treatment of Arm Laxity injectable poly-L-lactic acid, Normal Saline - Skin Laxity | Not applicable | Unknown | Goldman, Butterwick, Fitzpatrick and Groff | 20 | 2022-07-20 | 2022-07-06 |
| Treatment for Lifting Upper Arm Lax Skin Sofwave - Lax Skin | Not applicable | Completed | Sofwave Medical LTD | 50 | 2022-05-01 | 2023-11-18 |
| Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors Elimusertib - Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 31 | 2021-12-22 | 2026-01-23 |
| A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma | Phase 3 | Active not recruiting | Children's Oncology Group | 113 | 2021-09-14 | 2026-07-30 |
| Reliability and Acceptability of Real-time Virtual Video Pediatric Gait, Arms, Legs and Spine (V-pGALS) video Pediatric Gait, Arms, Legs and Spine (V-pGALS) - Musculoskeletal Abnormality, Pediatric | Not applicable | Completed | Marmara University | 20 | 2021-08-20 | 2021-10-14 |
| Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas dinutuximab beta - Bone Sarcoma, Embryonal Rhabdomyosarcoma | Phase 3 | Recruiting | N.N. Petrov National Medical Research Center of Oncology | 40 | 2021-05-20 | 2024-11-01 |
| Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma Biospecimen Collection, Laboratory Biomarker Analysis, Questionnaire Administration - Alveolar Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma | Active not recruiting | Children's Oncology Group | 900 | 2017-10-23 | 2026-02-06 | |
| Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma Dasatinib, Ganitumab - Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 14 | 2017-07-07 | 2022-04-14 |
| Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma Cyclophosphamide, Dactinomycin, Irinotecan Hydrochloride - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 325 | 2016-06-01 | 2026-10-01 |
| A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma TB-403 20mg/kg, TB-403 50mg/kg, TB-403 100mg/kg - Relapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS) | Phase 1 | Completed | Oncurious NV | 18 | 2016-05-01 | 2021-01-13 |
| LEVANT Japan Clinical Trial MD02-LDCB Paclitaxel coated balloon catheter, Standard Uncoated Balloon Angioplasty Catheter - Femoral Arterial Stenosis, Stenosis of Popliteal Arteries | Phase 2 | Completed | C. R. Bard | 110 | 2013-03-01 | 2016-09-28 |
| CREATE: Cross-tumoral Phase 2 With Crizotinib Crizotinib (PF-02341066) - Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 582 | 2012-09-01 | 2023-12-11 |
| Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries Standard Uncoated Angioplasty Balloon, Moxy Drug Coated Balloon - Femoral Artery Stenosis, Popliteal Artery Stenosis | Not applicable | Completed | C. R. Bard | 532 | 2011-07-01 | 2020-05-12 |
| Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis Taclonex Ointment and Hydrogel Patch, Taclonex Ointment - Plaque Psoriasis, Psoriasis Vulgaris | Phase 4 | Terminated | University of California, San Francisco | 35 | 2009-06-01 | 2019-04-18 |
| Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma Tumor Purged/CD25 Depleted Lymphocytes, Tumor Purged/CD25 Depleted Lymphocytes with Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine, rhIL-7 - Neuroblastoma, Sarcoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 44 | 2007-06-02 | 2018-06-15 |
| Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features Seneca Valley Virus (biological agent) - Carcinoid, Neuroendocrine | Phase 1 | Unknown | Neotropix | 60 | 2006-04-01 | 2010-02-25 |
Rhabdomyosarcoma, Embryonal (6) · Rhabdomyosarcoma (5) · Sarcoma, Ewing (4) · Neuroblastoma (3) · Cutis Laxa (2) · Medulloblastoma (2) · Bone Neoplasms (1) · Burnett Schwartz Berberian syndrome (1) · Carcinoid Tumor (1) · Glioblastoma (1) · Granuloma, Plasma Cell (1) · Lymphoma (1) · Lymphoma, Large-Cell, Anaplastic (1) · Musculoskeletal Abnormalities (1)
Myosarcoma (18) · Neoplasms by Histologic Type (18) · Neoplasms, Connective and Soft Tissue (18) · Neoplasms, Muscle Tissue (18) · Neoplasms (17) · Sarcoma (17) · Rhabdomyosarcoma (13) · Neoplasms, Connective Tissue (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Neoplasms, Bone Tissue (4) · Osteosarcoma (4) · Genetic Diseases, Inborn (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3)
Cyclophosphamide (2) · Dactinomycin (2) · Radiation (2) · Radiotherapy (2) · Vincristine (2) · Vinorelbine (2) · BAY 1895344 (1) · Biological Factors (1) · Biopsy (1) · Crizotinib (1) · Dasatinib (1) · Intense Pulsed Light Therapy (1) · Irinotecan (1) · Magnetic Resonance Spectroscopy (1) · Phantoms, Imaging (1)
National Cancer Institute (NCI) (4) · Goldman, Butterwick, Fitzpatrick and Groff (3) · C. R. Bard (2) · Children's Oncology Group (2) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Marmara University (1) · N.N. Petrov National Medical Research Center of Oncology (1) · Neotropix (1) · Oncurious NV (1) · Sofwave Medical LTD (1) · University of California, San Francisco (1)
United States (12) · Canada (3) · Australia (2) · Belgium (2) · Germany (2) · Puerto Rico (2) · Austria (1) · France (1) · Italy (1) · Japan (1) · Netherlands (1) · New Zealand (1) · Norway (1) · Poland (1) · Russia (1)
Abha A Gupta (1) · Christine M Heske, M.D. (1) · Esra Giray, assoc. prof (1) · Hiroyoshi Yokoi (1) · John Glod, M.D. (1) · John Koo, MD (1) · Kenneth Rosenfield, MD (1) · Michael V Ortiz (1) · Ozge Kenis-Coskun, assoc. prof (1) · Philip Lupo (1) · Prof. Dierk Scheinert (1) · Rudin Charles, MD, PhD (1) · Ruthie Amir, MD (1)
PMID 31575518, PMID 42573020, PMID 18391430, PMID 26106946, PMID 27117972, PMID 2753146, PMID 28926470, PMID 28950372, PMID 29216400, PMID 29567632, PMID 29669701, PMID 33129319, PMID 34392187, PMID 35319535, PMID 37398992, PMID 38603649, PMID 38936378, PMID 41914453
U10CA180886 (2), UM1CA228823 (1)